Dachaigh › Leukemia monocytic geur
Sgrùdaidhean clionaigeach Leukemia monocytic geur a’ fastadh anns na SA
Tha 8 sgrùdaidhean airson Leukemia monocytic geur a’ fastadh phàirtichean aig làraichean air feadh nan Stàitean Aonaichte.
Bailtean leis na sgrùdaidhean as motha
Le stàit
Sgrùdaidhean air an ùrachadh o chionn ghoirid
Teacsa sgrùdaidh oifigeil (Beurla)
Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Sult 2026 · NCT04282187Venetoclax in Combination With Cladribine and Cytarabine Alternating With Azacitidine Plus Venetoclax for the Treatment of Newly Diagnosed Monocytic AML and Active Signaling Mutated AML
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 16 Sult 2026 · NCT06504459Fractionated Gemtuzumab Ozogamicin in Treating Measurable Residual Disease in Patients With Acute Myeloid Leukemia
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 13 Lùna 2026 · NCT03737955Halt Aging in Survivors of Blood Cancers
A’ fastadh
Aoisean 50 agus nas sine · Gach gnè · Air ùrachadh 1 Iuch 2026 · NCT07292272211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome
A’ fastadhÌre 1/2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 22 Ògmh 2026 · NCT03670966Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)
A’ fastadhÌre 2
Aoisean 1 gu 60 · Gach gnè · Air ùrachadh 12 Màrt 2026 · NCT03970096A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Gearr 2026 · NCT06950034Mitoxantrone for Venetoclax Resistant Acute Myeloid Leukemia
A’ fastadhÌre 1
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 15 Faoi 2026 · NCT06429449Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.